Today: 27 June 2026
TMUS stock ends higher — T-Mobile’s $3 billion debt move and an ad-watchdog decision tee up the next catalysts
23 January 2026
1 min read

TMUS stock ends higher — T-Mobile’s $3 billion debt move and an ad-watchdog decision tee up the next catalysts

New York, January 22, 2026, 20:53 (EST) — The market has closed.

  • T-Mobile shares ended the day roughly 1% higher, closing at $185.39
  • Company plans to redeem $3 billion of its 4.75% senior notes maturing in 2028 on Feb. 1
  • The advertising appeals panel ruled that T-Mobile did not follow previous guidelines regarding its savings claims; investors now turn to February 11 for updates

T-Mobile US shares climbed roughly 1% to $185.39 on Thursday. Following the market close, the company announced that its T-Mobile USA division will redeem $3 billion of 4.75% senior notes maturing in 2028, effective Feb. 1.

The debt move comes at a sensitive time for U.S. telecom stocks, as investors juggle concerns over balance-sheet discipline with ongoing network investments and a competitive pricing environment. For T-Mobile, retiring a sizable 2028 maturity cuts refinancing risk ahead of a packed schedule of investor events.

Thursday’s rise came alongside a stronger overall market. U.S. indexes closed up as investors drew some relief from President Donald Trump easing off tariff threats, with economic data showing signs of strength. “You do not know whether it is Christmas morning or Friday the 13th,” said Gregg Abella, CEO of Investment Partners Asset Management. Reuters

Simply put, the “senior notes” are corporate bonds, and a redemption means an early payoff. T-Mobile announced that holders will receive 100% of the principal plus any accrued interest up to, but not including, the redemption date.

Separately, the National Advertising Review Board, which handles appeals in BBB National Programs’ self-regulatory ad system, found that T-Mobile didn’t follow through on recommendations regarding cost-savings claims for its wireless plans. Rival Verizon had filed the original complaint. NARB ruled that even after T-Mobile updated its disclaimer, it still failed to make clear that the comparisons included extra services beyond basic cellular coverage.

Verizon shares climbed roughly 0.6%, with AT&T gaining about 0.4%, keeping the sector mostly aligned with the broader market bounce.

Benchmark’s Matthew Harrigan stood by his Buy rating on T-Mobile Wednesday, setting a $295 price target, data from TipRanks shows.

On the flip side, paying down debt eats into cash reserves. If the advertising spat heats up or the sector sees another round of aggressive promotions, it could squeeze both margins and subscriber growth expectations.

With markets closed today, traders are set to monitor Friday’s session closely for any fallout from the post-close debt announcement and potential ripple effects from the ad-ruling news.

Mark your calendars: the bond redemption deadline hits Feb. 1. T-Mobile’s Q4 2025 earnings call and capital markets day update will follow on Feb. 11 at 8:30 a.m. ET.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Wait 90 Days Before Buying More SpaceX Stock Due to Upcoming Share Unlocks
    June 27, 2026, 12:00 PM EDT. Space Exploration Technologies (SpaceX) recently made a record-breaking $75 billion initial public offering (IPO), valuing the company at $1.77 trillion. Although its stock briefly surged, it has dropped 3% since debut. Investors should consider waiting 90 days before buying more shares due to an upcoming lockup period, during which insiders are restricted from selling. After this period, additional shares will enter the market, potentially pressuring the stock price downward. SpaceX only floated about 4% of shares initially, with gradual increases expected over time. Historically, blockbuster IPOs often underperform in their first years, so patience and reassessment after the lockup expiration in September is advised to gauge true market response and valuation.

Latest articles

PayPal stock surge shifts short-interest story into next week

PayPal stock surge shifts short-interest story into next week

27 June 2026
PayPal surged 4.5% to $44.29 Friday on trading volume more than double its 65-day average, following a 9.7% jump in short interest to 54.35 million shares as of June 15, equal to 6.2% of float; despite the rally, shares remain 44% below last year’s high, with the stock still seen as a turnaround play and a shortened trading week ahead due to the July 3 U.S. holiday.
Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

Uber (NYSE:UBER) grabs $4.9 billion run as safety, robotaxis in focus

27 June 2026
Uber surged 5.47% to $76.20 on Friday with trading volume 3.46 times its 65-day average, as investors weighed tighter U.S. driver background checks set to remove tens of thousands of gig workers starting Monday—raising potential impacts on trips, wait times, and margins while the stock remains 25.3% below its 52-week high.
Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

Honeywell (NASDAQ:HON) heads into split week with $464 level on traders’ radar

27 June 2026
Honeywell’s two-for-one split launches Monday, giving investors one Honeywell Technologies share and one Honeywell Aerospace (HONA) share for every two old shares, with the combined package valued at $464.42 at Friday’s close; both stocks debut as separate S&P 500 members, while HONA joins the S&P 100, setting up a pivotal test for holders as the market reopens.
Generate Biomedicines stock ends week back above IPO price as volume jumps

Generate Biomedicines stock ends week back above IPO price as volume jumps

27 June 2026
Generate Biomedicines (NASDAQ:GENB) surged 13.7% since June 18 to close Friday at $16.47—above its $16 IPO price—with heavy volume and a $2.11B market cap, as investors weigh its $516.6M cash pile, ongoing clinical trial risks, and lack of product revenue, while sector momentum lifts biotech stocks.
Autodesk layoffs: AutoCAD maker to cut 1,000 jobs as it shifts spending to AI and cloud
Previous Story

Autodesk layoffs: AutoCAD maker to cut 1,000 jobs as it shifts spending to AI and cloud

British American Tobacco share price in focus before London open after buyback disclosure
Next Story

British American Tobacco share price in focus before London open after buyback disclosure

Go toTop